96
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Enhanced antitumor efficacy of poly(D,L-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice

, , , , , & show all
Pages 3065-3075 | Published online: 20 Oct 2017

References

  • SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin2017671 7 3028055103
  • ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin2016662 115 13226808342
  • SaltzmanWMFungLKPolymeric implants for cancer chemotherapyAdv Drug Deliv Rev1997262–3 209 23010837544
  • GoldbergEPHadbaARAlmondBAMarottaJSIntratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug deliveryJ Pharm Pharmacol2002542 159 18011848280
  • WeinbergBDBlancoEGaoJPolymer implants for intratumoral drug delivery and cancer therapyJ Pharm Sci2008975 1681 170217847077
  • Hohenforst-SchmidtWZarogoulidisPDarwicheKIntratumoral chemotherapy for lung cancer: re-challenge current targeted therapiesDrug Des Devel Ther20137 571 583
  • WolinskyJBColsonYLGrinstaffMWLocal drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafersJ Control Release20121591 14 2622154931
  • AbolmaaliSSTamaddonAMDinarvandRA review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritisCancer Chemother Pharmacol2013715 1115 113023292116
  • Pereira AdeFPereiraLGBarbosaLAEfficacy of methotrexate-loaded poly(epsilon-caprolactone) implants in Ehrlich solid tumor-bearing miceDrug Deliv2013203–4 168 17923738591
  • GenestierLPaillotRQuemeneurLIzeradjeneKRevillardJPMechanisms of action of methotrexateImmunopharmacology2000472–3 247 25710878292
  • MisraRMohantySSustained release of methotrexate through liquid-crystalline folate nanoparticlesJ Mater Sci Mater Med2014259 2095 210924952639
  • GaiesEJebabliNMethotrexate Side Effects: Review ArticleJ Drug Metab Toxicol201234 1 5
  • Al-QuteimatOMAl-BadainehMAPractical issues with high dose methotrexate therapySaudi Pharm J2014224 385 38725161385
  • SinghUVPandeySUmadeviPUdupaNPreparation, characterization, and antitumor efficacy of biodegradable poly(lactic acid) methotrexate implantable filmsDrug Delivery199742 101 106
  • KapoorDNBhatiaAKaurRSharmaRKaurGDhawanSPLGA: a unique polymer for drug deliveryTher Deliv201561 41 5825565440
  • The State Pharmacopoeia Commission of People’s Republic of ChinaThe Pharmacopoeia of the People’s Republic of ChinaBeijing: ChinaMedical Science Press2015
  • GaoLXieCDuYCharacterization and antitumor efficacy of poly(L-lactid acid)-based etoposide-loaded implantsDrug Deliv2017241 765 77428475414
  • DongYChinSFBlancoEIntratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapyClin Cancer Res2009151 131 13919118040
  • DongWZhangLNiuYA stable and practical etoposide-containing intravenous long-/medium-chain triglycerides-based lipid emulsion formulation: pharmacokinetics, biodistribution, toxicity, and antitumor efficacyExpert Opin Drug Deliv2013105 559 57123373755
  • MitchellDACuiXSchmittlingRJMonoclonal antibody blockade of IL-2 receptor alpha during lymphopenia selectively depletes regulatory T cells in mice and humansBlood201111811 3003 301221768296
  • AyyappanSSundaraganesanNAroulmojiVMuranoESebastianSMolecular structure, vibrational spectra and DFT molecular orbital calculations (TD-DFT and NMR) of the antiproliferative drug MethotrexateSpectrochim Acta A Mol Biomol Spectrosc2010771 264 27520621610
  • GharebaghiFDalaliNAhmadiEDanafarHPreparation of wormlike polymeric nanoparticles coated with silica for delivery of methotrexate and evaluation of anticancer activity against MCF7 cellsJ Biomater Appl2017319 1305 131628447548
  • de Fatima PereiraAMara da CostaVCristina Magalhaes SantosMEvaluation of the effects of methotrexate released from polymeric implants in solid Ehrlich tumorBiomed Pharmacother2014683 365 36824529847
  • XuYKimCSSaylorDMKooDPolymer degradation and drug delivery in PLGA-based drug-polymer applications: a review of experiments and theoriesJ Biomed Mater Res B Appl Biomater20171056 1692 171627098357
  • El-BadryMFetihGFathyMImprovement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000Saudi Pharm J2009173 217 22523964164
  • ChengLLeiLGuoSIn vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blendsInt J Pharm20103871–2 129 13820005928
  • WangKZhangXZhangLDevelopment of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral releaseDrug Deliv2015223 389 39924670095
  • SolanoAGde Fatima PereiraAPintoFCDevelopment and evaluation of sustained-release etoposide-loaded poly(epsilon-caprolactone) implantsAAPS PharmSciTech2013142 890 90023666789
  • ChadhaRAroraPKaurRSainiASinglaMLJainDSCharacterization of solvatomorphs of methotrexate using thermoanalytical and other techniquesActa Pharm2009593 245 25719819822
  • LiCChengLZhangYGuoSWuWEffects of implant diameter, drug loading and end-capping on praziquantel release from PCL implantsInt J Pharm20103861–2 23 2919895876
  • WongPTChoiSKMechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic deliveryInt J Mol Sci2015161 1772 179025590303
  • RotmanMRosenthalCJConcomitant Continuous Infusion Chemotherapy and Radiation1st edBerlin HeidelbergSpringer-verlag1991